Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心

北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ：PRAH）今天宣布任命Isaac...
November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados

RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
November 23, 2020 14:28 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés

RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...
November 19, 2020 16:02 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
November 04, 2020 16:01 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance

Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
October 07, 2020 17:09 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences to Report Third Quarter 2020 Earnings

RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences dipilih oleh BARDA untuk menjadi ahli Rangkaian Kajian Klinikal yang eksklusifnya

Dengan kontrak baharu, PRA akan membantu Lembaga Penyelidikan dan Pembangunan Lanjutan Bioperubatan (BARDA) dalam pembangunan langkah balas perubatan untuk kesihatan orang awam RALEIGH, N.C., Oct. ...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA 헬스사이언스, BARDA로부터 임상 연구 네트워크 회원사로 선정

미국 노스캐롤라이나주 롤리, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 미국 생물의약품첨단연구개발국(BARDA)으로부터 업데이트된 임상연구 네트워크(Clinical Studies Network) 회원사로 등록되었다고 밝혔다. 임상시험 계획 및...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

PRA Health Sciences von BARDA als Mitglied des exklusiven Clinical Studies Network ausgewählt

Mit dem neuen Vertrag wird PRA die Biomedical Advanced Research and Development Authority (BARDA) bei der Entwicklung medizinischer Maßnahmen für die öffentliche Gesundheit unterstützen RALEIGH,...
October 07, 2020 11:10 ET | Source: PRA Health Sciences, Inc.

BARDA 選擇 PRA Health Sciences 作為為其專屬臨床研究網絡的成員

新澤西州拉里市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈公司已獲生物醫學高級研究和開發管理局 (BARDA) 選為最新臨床研究網絡 (CSN) 的成員。PRA 獲授予臨床試驗計劃和執行 (CTPE)...